Prudential Financial
KRYS icon

Prudential Financial’s Krystal Biotech KRYS Stock Holding History

Prudential Financial’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.1M Buy
32,662
+3,024
+10% +$904K 0.01% 615
2026
Q1 		$7.66M Buy
29,638
+2,623
+10% +$698K 0.01% 739
2025
Q4 		$6.66M Buy
27,015
+1,519
+6% +$320K 0.01% 795
2025
Q3 		$4.5M Sell
25,496
-655
-3% -$98K 0.01% 995
2025
Q2 		$4.42M Sell
26,151
-1,160
-4% -$170K 0.01% 980
2025
Q1 		$4.92M Sell
27,311
-13,882
-34% -$2.34M 0.01% 848
2024
Q4 		$6.82M Buy
41,193
+3,254
+9% +$577K 0.01% 754
2024
Q3 		$6.91M Sell
37,939
-8,599
-18% -$1.66M 0.01% 837
2024
Q2 		$8.55M Buy
46,538
+8,693
+23% +$1.46M 0.01% 706
2024
Q1 		$6.73M Sell
37,845
-1,711
-4% -$238K 0.01% 814
2023
Q4 		$4.91M Sell
39,556
-30
-0.1% -$3.33K 0.01% 942
2023
Q3 		$4.66M Buy
39,586
+29,895
+308% +$3.65M 0.01% 920
2023
Q2 		$1.14M Buy
+9,691
New +$989K ﹤0.01% 1747
2023
Q1 		– Sell
-5,096
Closed -$404K – 2638
2022
Q4 		$404K Sell
5,096
-2,795
-35% -$207K ﹤0.01% 2120
2022
Q3 		$550K Sell
7,891
-3,050
-28% -$220K ﹤0.01% 2032
2022
Q2 		$718K Sell
10,941
-9,950
-48% -$619K ﹤0.01% 1952
2022
Q1 		$1.39M Buy
+20,891
New +$1.3M ﹤0.01% 1717

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Prudential Financial's KRYS Position: Q2 2026 in Review

Prudential Financial increased its Krystal Biotech (KRYS) stake by 10% in Q2 2026, buying an estimated $904K and bringing the position to 32,662 shares worth $12.1M. The position accounts for 0.01% of the portfolio, ranked #615.

Prudential Financial first reported a position in KRYS in Q1 2022 and has held it in 17 quarters since. 424 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Prudential Financial held 32,662 shares of Krystal Biotech worth $12.1M as of Q2 2026.
  • Prudential Financial bought 3,024 Krystal Biotech shares in Q2 2026, an estimated $904K.
  • Krystal Biotech made up 0.01% of Prudential Financial's portfolio in Q2 2026, its #615 holding.
  • Prudential Financial first reported a position in Krystal Biotech in Q1 2022 and has held it in 17 quarters since.
  • 424 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.